Principal Investigator
Byron Lam
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20250729
Clinical Trial Summary
A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants with X-linked Retinitis Pigmentosa
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other